We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Safety and Tolerability of Oral Clofarabine in Intermediate to High Risk Myelodysplastic Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01003678
Recruitment Status : Terminated (Drug provider withdrew support)
First Posted : October 29, 2009
Last Update Posted : June 3, 2016
Genzyme, a Sanofi Company
Information provided by (Responsible Party):
Roswell Park Cancer Institute

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Primary Completion Date : June 2013
  Study Completion Date : October 2013